Addition of rifampin to conventional therapy for recurrent furunculosis.
Hoss
D M
DM
University of Connecticut Health Center, Farmington, USA.
Feder
H M
HM
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D002506:Cephalexin / Q000008:administration & dosage / Q000627:therapeutic use*; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use; D003023:Cloxacillin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005667:Furunculosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016712:Mupirocin / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*
D016712:Mupirocin; D003023:Cloxacillin; D002506:Cephalexin; D002710:Chlorhexidine; D012293:Rifampin